As of 2026-04-07, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 112.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.90 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is 63.9%.
The range of the Relative Valuation is 77.69 - 182.50 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.4x - 15.3x | 10.8x |
| Forward P/E multiples | 10.0x - 21.1x | 15.8x |
| Fair Price | 77.69 - 182.50 | 112.95 |
| Upside | 12.8% - 164.9% | 63.9% |
| Date | P/E |
| 2026-04-06 | 8.35 |
| 2026-04-02 | 8.22 |
| 2026-04-01 | 8.34 |
| 2026-03-31 | 8.26 |
| 2026-03-30 | 7.96 |
| 2026-03-27 | 8.02 |
| 2026-03-26 | 8.12 |
| 2026-03-25 | 8.09 |
| 2026-03-24 | 7.83 |
| 2026-03-23 | 8.05 |
| 2026-03-20 | 7.92 |
| 2026-03-19 | 8.13 |
| 2026-03-18 | 8.12 |
| 2026-03-17 | 8.18 |
| 2026-03-16 | 8.09 |
| 2026-03-13 | 7.82 |
| 2026-03-12 | 7.68 |
| 2026-03-11 | 7.96 |
| 2026-03-10 | 8.31 |
| 2026-03-09 | 8.29 |
| 2026-03-06 | 7.62 |
| 2026-03-05 | 7.68 |
| 2026-03-04 | 7.80 |
| 2026-03-03 | 7.81 |
| 2026-03-02 | 8.05 |
| 2026-02-27 | 8.27 |
| 2026-02-26 | 8.26 |
| 2026-02-25 | 8.22 |
| 2026-02-24 | 8.36 |
| 2026-02-23 | 8.55 |
| 2026-02-20 | 8.57 |
| 2026-02-19 | 8.48 |
| 2026-02-18 | 8.36 |
| 2026-02-17 | 8.39 |
| 2026-02-13 | 8.42 |
| 2026-02-12 | 8.57 |
| 2026-02-11 | 8.60 |
| 2026-02-10 | 8.75 |
| 2026-02-09 | 8.99 |
| 2026-02-06 | 9.05 |
| 2026-02-05 | 8.77 |
| 2026-02-04 | 8.96 |
| 2026-02-03 | 9.07 |
| 2026-02-02 | 9.08 |
| 2026-01-30 | 9.16 |
| 2026-01-29 | 9.27 |
| 2026-01-28 | 9.17 |
| 2026-01-27 | 9.15 |
| 2026-01-26 | 9.24 |
| 2026-01-23 | 9.12 |